Healthcare Stocks Investors Sold August 30th

At the close of trading on Tuesday, August 30, 2011, these stocks brought down the Healthcare (NYSE:XLV) sector. Long time Wall St. Cheat Sheet readers know to watch stock prices because Technicals on the Stock Chart are Strong’ is one of the ‘T’s in our CHEAT SHEET investing framework.

Bristol-Myers Squibb Company (NYSE:BMY) was among the price losers in the sector as its stock price closed at $29.12, down 17 cents (-0.6%) from the previous close of $29.29. Bristol-Myers Squibb Company is a global company which develops, manufactures and sells pharmaceutical products.

Stock Price Performance: From June 2, 2011, to August 26, 2011, the stock price had risen 95 cents (3.4%) from $27.77 to $28.72. The stock price saw one of its best stretches over the last year between August 30, 2010 and September 13, 2010 when shares rose for 10 straight trading days, rising 5.1% (+$1.25). It saw one of its worst periods between January 3, 2011 and January 11, 2011 when shares fell for seven straight trading days, falling 2.5% (-63 cents).

Shares of Medtronic Inc. (NYSE:MDT) closed at $34.58, down 21 cents (-0.6%) from the previous close of $34.79. Medtronic provides products and therapies for medical professionals to meet the healthcare needs of their patients.

Stock Price Performance: From June 2, 2011, to August 26, 2011, the stock price had fallen $4.89 (-12.6%) from $38.94 to $34.05. The stock price saw one of its best stretches over the last year between March 22, 2011 and March 30, 2011 when shares rose for seven straight trading days, rising 4.7% (+$1.75). It saw one of its worst periods between May 18, 2011 and May 25, 2011 when shares fell for six straight trading days, falling 6.9% (-$2.95).

Stryker Corporation (NYSE:SYK) was among the price losers in the sector as its stock price closed at $47.69, down 35 cents (-0.7%) from the previous close of $48.04. Stryker is a medical technology firm, which produces a range of products in medical implants, surgical technologies and emergency medical equipment. It is divided into two segments, which are Orthopaedic Implants and MedSurg Equipment.

Stock Price Performance: From June 2, 2011, to August 26, 2011, the stock price had fallen $14.65 (-24.1%) from $60.82 to $46.17. The stock price saw one of its best stretches over the last year between May 6, 2011 and May 18, 2011 when shares rose for nine straight trading days, rising 7.2% (+$4.30). It saw one of its worst periods between May 19, 2011 and May 27, 2011 when shares fell for seven straight trading days, falling 2.9% (-$1.83).

DENTSPLY International Inc. (NASDAQ:XRAY) was among the price losers in the sector. Its shares closed at $34.75, which is 40 cents (-1.1%) below the previous close of $35.15. DENTSPLY International, Inc. manufactures and distributes dental equipment and products, including artificial teeth and dental consumable products.

Stock Price Performance: From July 1, 2011, to August 29, 2011, the stock price had fallen $3.37 (-8.7%) from $38.52 to $35.15. The stock price saw one of its best stretches over the last year between June 27, 2011 and July 8, 2011 when shares rose for nine straight trading days, rising 5.6% (+$2.07). It saw one of its worst periods between May 31, 2011 and June 8, 2011 when shares fell for seven straight trading days, falling 5.7% (-$2.22).

Shares of Pharmaceutical Product Development, Inc. (NASDAQ:PPDI) closed at $30.89, down 43 cents (-1.4%) from the previous close of $31.32. Pharmaceutical Product Development, Inc. is a global contract research organization, which provides drug discovery and development services, post-approval expertise and compound partnering programs.

Stock Price Performance: From June 3, 2011, to August 29, 2011, the stock price had risen $4.21 (15.5%) from $27.11 to $31.32. The stock price saw one of its best stretches over the last year between December 7, 2010 and December 16, 2010 when shares rose for eight straight trading days, rising 7.5% (+$1.86). It saw one of its worst periods between March 9, 2011 and March 18, 2011 when shares fell for eight straight trading days, falling 5.5% (-$1.58).